Evidence method
Level · gp.fundamentals.capex_revenue_ratio
202.36% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
ABCL · Dec 31, 2023
AbCellera Biologics Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001703057-24-000019General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-115.39% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-92.17% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-623.82% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
461.95% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
168.79% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History18 statesSelf-history eligible
Mar 31, 20220/6 normalizedLevel 3Jun 30, 20220/6 normalizedLevel 3Sep 30, 20220/6 normalizedLevel 3Dec 31, 20220/6 normalizedLevel 3Mar 31, 20235/6 normalizedLevel 3Jun 30, 20235/6 normalizedLevel 3Sep 30, 20235/6 normalizedLevel 3Dec 31, 20235/6 normalizedLevel 3Mar 31, 20246/6 normalizedLevel 3Jun 30, 20246/6 normalizedLevel 3Sep 30, 20246/6 normalizedLevel 3Dec 31, 20246/6 normalizedLevel 3Mar 31, 20256/6 normalizedLevel 3Jun 30, 20256/6 normalizedLevel 3Sep 30, 20256/6 normalizedLevel 3Dec 31, 20256/7 normalizedLevel 3Mar 31, 20266/7 normalizedLevel 3Jun 30, 20266/7 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 308.09%
- Current
- 202.36%
- Delta
- -105.73%
- Previous
- -1.61%
- Current
- -115.39%
- Delta
- -113.78%
- Previous
- -93.49%
- Current
- -92.17%
- Delta
- 1.32%
- Previous
- -831.79%
- Current
- -623.82%
- Delta
- 207.97%
- Previous
- 574.59%
- Current
- 461.95%
- Delta
- -112.63%
- Previous
- 240.37%
- Current
- 168.79%
- Delta
- -71.58%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · ABCL Fundamental State →Analogous To · ABCL state analogue 3 →Transitioned To · ABCL Fundamental State →Transitioned To · ABCL CAPEX_INTENSITY_DECREASED →Transitioned To · ABCL CASH_GENERATION_DECREASED →Transitioned To · ABCL GROWTH_INCREASED →Transitioned To · ABCL PROFITABILITY_INCREASED →Transitioned To · ABCL R_AND_D_INTENSITY_DECREASED →Transitioned To · ABCL SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.